Artivion | CRY - 普通股股本

金融业

USD 22.98

USD 1.07B

现金及等价物

USD 77.32M

USD 42.85M

USD 371.38M

USD 106.93M

USD 317.78M

USD 4.79M

USD 22.72M

1.5K

EPS每股收益

USD -0.02

股本和储备

USD 445.59M

USD 73.14M

债务利息支出

USD 5.53M

USD -0.05

USD 363.42M

USD 952.7M

USD 2.42M

USD 111.2M

USD 4.79M

普通股股本

USD 47.84M

212.38

USD 11.4M

USD 115.99M

销售和管理费用

USD 55.75M

USD 103.36M

贸易债权人

USD 20.87M

应收帐款人

USD 103.68M

	普通股股本	更改		日
Abbott	USD 1.74B		2.94M	2026-03
Accuray	USD 100K		1000	2024-09
AngioDynamics	USD 41.57M		127K	2025-09
Artivion	USD 47.84M		468K	2025-12
AtriCure	USD 50.64M		7K	2026-06
Baxter International	USD 517M		549K	2026-06
Becton, Dickinson and Co.	USD 370.59M		95.05M	2026-06
Boston Scientific	USD 1.48B		2.66M	2025-12
Edwards Lifesciences	USD 577M		3.7M	2026-03
Inogen	USD 23K		0	2023-12
Integra LifeSciences	USD 77.78M		39K	2026-06
J&J	USD 2.41B		1.64M	2026-06
Mesa Laboratories	USD 349.53M		3.53M	2024-09
Orthofix International	USD 39.83M		315K	2025-12
Pfizer	USD 5.7B		0	2026-06
ResMed	USD 145.06M		45.78M	2026-06
Stryker	USD 383.4M		416K	2026-06
Tandem Diabetes Care	USD 69.54M		1.04M	2026-06
Teleflex	USD 42.37M		1.89M	2026-06
Terumo	JPY 1.48B		19K	2026-06
Trinity Biotech	USD 386.76M		1.57M	2025-12